TP53 and neoplasm: C1 and C3 manifested BRAF-like tumor characteristics, with C1 having the lowest TDS and significant activation of thyroid autoimmune, MAPK, TP53 and TERT-related signaling pathways, while C3 showed activation of the PI3K-Akt and Ras signaling pathways.